Type 1 and type 2 diabetes, insulin resistance, glucose metabolism, and metabolic health
263 articles
Allez au-delà des notions fondamentales et explorez les mécanismes biochimiques de la glycation — de la cascade de la réaction de Maillard à la signalisation RAGE et aux pontages tissulaires — pour comprendre pourquoi les AGEs sont au cœur du vieillissement et des maladies métaboliques.
Découvrez comment les molécules de sucre endommagent silencieusement vos protéines et vos cellules au fil du temps — et ce que vous pouvez faire pour ralentir ce processus de vieillissement sournois.
FDA approval of the first T1D delay drug nearly doubled islet autoantibody testing, but critical gaps remain in screening healthy children.
A new review links feline age-related obesity to SASP-driven chronic inflammation, offering translational insights for human metabolic disease.
The triple agonist retatrutide drives deep metabolic shifts beyond weight loss, improving key biomarkers of cardiovascular and insulin health.
Diabetes drugs like empagliflozin show surprising anti-aging effects — mimicking caloric restriction and reducing senescent cell burden.
Three new NIH-funded findings tackle metabolic aging, cardiovascular risk, and a surprising hormonal brake on brain tumors.
A rigorous MRI-based study finds that repeated hypoglycemia episodes leave brain glucose transport kinetics unchanged, challenging a leading hypothesis.
A novel endoluminal device implanted in the gut improved insulin sensitivity and weight control beyond what semaglutide achieved in a pig model.
A head-to-head review of 10 CGM devices for healthy adults, weighing real-world accuracy data against limited longevity evidence.
Three NIH-funded studies this week tackle metabolic decline, cardiac risk, and brain tumors — all with aging implications.
A major Cochrane network meta-analysis protocol will rank all insulin regimens by efficacy and safety for adults with type 1 diabetes.
